S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

AADI Aadi Bioscience Inc

1.7999

-0.0001 (-0.01%)

Pre Market

Last Updated: 22:00:06

Delayed by 15 minutes

Aadi Bioscience rises on CFO appointment

To read the full story on Seeking Alpha, click here.

Aadi Bioscience (NASDAQ:AADI)
Historical Stock Chart
From Mar 2024 to Apr 2024

Click Here for more Aadi Bioscience Charts.

Aadi Bioscience (NASDAQ:AADI)
Historical Stock Chart
From Apr 2023 to Apr 2024

Click Here for more Aadi Bioscience Charts.

Aadi Bioscience Inc News

Aadi Bioscience to Present New Non-clinical Data Highlighting Combinability of nab-Sirolimus at the American Association for Cancer Research (AACR) Annual Meeting
Tuesday 9 April 2024 (1 week ago) • PR Newswire (US)

Aadi Bioscience Presents New Subgroup Analysis of Patients with Advanced Malignant PEComa of Gynecologic Origin Treated with nab-Sirolimus at Society of Gynecologic Oncology (SGO)
Sunday 17 March 2024 (1 month ago) • PR Newswire (US)

Aadi Bioscience Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Corporate Update
Wednesday 13 March 2024 (1 month ago) • PR Newswire (US)

Aadi Bioscience to Report Fourth Quarter and Full-Year 2023 Results and Corporate Update
Thursday 7 March 2024 (1 month ago) • PR Newswire (US)

Aadi Bioscience to Present Multiple Posters at the American Association for Cancer Research (AACR) Annual Meeting 2024
Wednesday 6 March 2024 (1 month ago) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 5 March 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 5 March 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 5 March 2024 (1 month ago) • Edgar (US Regulatory)

Aadi Bioscience Announces Publication of Long-Term Efficacy and Safety Data Further Supporting FYARRO® for the Treatment of Malignant PEComa
Saturday 2 March 2024 (2 months ago) • PR Newswire (US)

Form 144 - Report of proposed sale of securities
Saturday 2 March 2024 (2 months ago) • Edgar (US Regulatory)

Aadi Bioscience to Present at the TD Cowen 44th Annual Healthcare Conference
Tuesday 27 February 2024 (2 months ago) • PR Newswire (US)

Form S-8 - Securities to be offered to employees in employee benefit plans
Tuesday 13 February 2024 (2 months ago) • Edgar (US Regulatory)

More Aadi Bioscience Inc News Articles

Gold vs US Dollar

JP Morgan Chase

Newcrest Mining

AUD vs US Dollar

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions